vs
Acadia Healthcare Company, Inc.（ACHC）与西联汇款（WU）财务数据对比。点击上方公司名可切换其他公司
西联汇款的季度营收约是Acadia Healthcare Company, Inc.的1.2倍（$982.7M vs $821.5M），西联汇款净利率更高（6.6% vs -143.3%，领先149.9%），Acadia Healthcare Company, Inc.同比增速更快（6.1% vs 0.0%），过去两年Acadia Healthcare Company, Inc.的营收复合增速更高（3.4% vs -1.9%）
阿卡迪亚医疗公司是美国的营利性行为医疗健康服务提供商，目前在美国及波多黎各地区运营着超过225家医疗机构，搭建了覆盖广泛的行为健康服务网络，为有相关需求的人群提供专业的心理健康与行为干预服务。
西联汇款是总部位于美国科罗拉多州丹佛市的跨国金融服务企业，在全球范围内为个人及机构用户提供便捷的跨境汇款、支付等相关金融服务，凭借广泛的服务网点覆盖和成熟的业务体系，在跨境资金流转领域拥有较高的行业知名度。
ACHC vs WU — 直观对比
营收规模更大
WU
是对方的1.2倍
$821.5M
营收增速更快
ACHC
高出6.1%
0.0%
净利率更高
WU
高出149.9%
-143.3%
两年增速更快
ACHC
近两年复合增速
-1.9%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $821.5M | $982.7M |
| 净利润 | $-1.2B | $64.7M |
| 毛利率 | — | — |
| 营业利润率 | -142.4% | 12.5% |
| 净利率 | -143.3% | 6.6% |
| 营收同比 | 6.1% | 0.0% |
| 净利润同比 | -3710.4% | -47.6% |
| 每股收益（稀释后） | $-12.98 | $0.41 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACHCWU
| Q1 26 | — | $982.7M | ||
| Q4 25 | $821.5M | $972.0M | ||
| Q3 25 | $851.6M | $985.3M | ||
| Q2 25 | $869.2M | $983.6M | ||
| Q1 25 | $770.5M | $938.7M | ||
| Q4 24 | $774.2M | $1.0B | ||
| Q3 24 | $815.6M | $993.4M | ||
| Q2 24 | $796.0M | $1.0B |
净利润ACHCWU
| Q1 26 | — | $64.7M | ||
| Q4 25 | $-1.2B | $114.4M | ||
| Q3 25 | $36.2M | $139.6M | ||
| Q2 25 | $30.1M | $122.1M | ||
| Q1 25 | $8.4M | $123.5M | ||
| Q4 24 | $32.6M | $385.7M | ||
| Q3 24 | $68.1M | $264.8M | ||
| Q2 24 | $78.5M | $141.0M |
毛利率ACHCWU
| Q1 26 | — | — | ||
| Q4 25 | — | 33.6% | ||
| Q3 25 | — | 34.7% | ||
| Q2 25 | — | 34.6% | ||
| Q1 25 | — | 34.0% | ||
| Q4 24 | — | 35.0% | ||
| Q3 24 | — | 34.2% | ||
| Q2 24 | — | 35.0% |
营业利润率ACHCWU
| Q1 26 | — | 12.5% | ||
| Q4 25 | -142.4% | 19.1% | ||
| Q3 25 | 4.7% | 20.5% | ||
| Q2 25 | 5.8% | 19.6% | ||
| Q1 25 | 1.7% | 18.9% | ||
| Q4 24 | 4.9% | 17.5% | ||
| Q3 24 | 12.1% | 16.6% | ||
| Q2 24 | 13.4% | 18.7% |
净利率ACHCWU
| Q1 26 | — | 6.6% | ||
| Q4 25 | -143.3% | 11.8% | ||
| Q3 25 | 4.3% | 14.2% | ||
| Q2 25 | 3.5% | 12.4% | ||
| Q1 25 | 1.1% | 13.2% | ||
| Q4 24 | 4.2% | 37.9% | ||
| Q3 24 | 8.4% | 26.7% | ||
| Q2 24 | 9.9% | 13.8% |
每股收益（稀释后）ACHCWU
| Q1 26 | — | $0.41 | ||
| Q4 25 | $-12.98 | $0.36 | ||
| Q3 25 | $0.40 | $0.43 | ||
| Q2 25 | $0.33 | $0.37 | ||
| Q1 25 | $0.09 | $0.36 | ||
| Q4 24 | $0.36 | $1.14 | ||
| Q3 24 | $0.74 | $0.78 | ||
| Q2 24 | $0.85 | $0.41 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $133.2M | $909.2M |
| 总债务越低越好 | $2.5B | — |
| 股东权益账面价值 | $1.9B | $910.5M |
| 总资产 | $5.5B | $8.1B |
| 负债/权益比越低杠杆越低 | 1.28× | — |
8季度趋势，按日历期对齐
现金及短期投资ACHCWU
| Q1 26 | — | $909.2M | ||
| Q4 25 | $133.2M | $1.2B | ||
| Q3 25 | $118.7M | $947.8M | ||
| Q2 25 | $131.4M | $1.0B | ||
| Q1 25 | $91.2M | $1.3B | ||
| Q4 24 | $76.3M | $1.5B | ||
| Q3 24 | $82.1M | $1.1B | ||
| Q2 24 | $77.2M | $1.0B |
总债务ACHCWU
| Q1 26 | — | — | ||
| Q4 25 | $2.5B | $2.9B | ||
| Q3 25 | $2.3B | $2.5B | ||
| Q2 25 | $2.3B | $2.5B | ||
| Q1 25 | $2.2B | $2.5B | ||
| Q4 24 | $2.0B | $3.0B | ||
| Q3 24 | $1.9B | $2.1B | ||
| Q2 24 | $1.8B | $2.1B |
股东权益ACHCWU
| Q1 26 | — | $910.5M | ||
| Q4 25 | $1.9B | $957.8M | ||
| Q3 25 | $3.1B | $925.4M | ||
| Q2 25 | $3.1B | $883.6M | ||
| Q1 25 | $3.0B | $939.4M | ||
| Q4 24 | $3.1B | $968.9M | ||
| Q3 24 | $3.0B | $652.7M | ||
| Q2 24 | $3.0B | $440.8M |
总资产ACHCWU
| Q1 26 | — | $8.1B | ||
| Q4 25 | $5.5B | $8.3B | ||
| Q3 25 | $6.4B | $7.8B | ||
| Q2 25 | $6.3B | $8.0B | ||
| Q1 25 | $6.1B | $8.3B | ||
| Q4 24 | $6.0B | $8.4B | ||
| Q3 24 | $5.9B | $7.7B | ||
| Q2 24 | $5.7B | $8.0B |
负债/权益比ACHCWU
| Q1 26 | — | — | ||
| Q4 25 | 1.28× | 3.01× | ||
| Q3 25 | 0.74× | 2.70× | ||
| Q2 25 | 0.74× | 2.83× | ||
| Q1 25 | 0.72× | 2.61× | ||
| Q4 24 | 0.64× | 3.04× | ||
| Q3 24 | 0.62× | 3.29× | ||
| Q2 24 | 0.62× | 4.88× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-86.3M | $109.0M |
| 自由现金流经营现金流 - 资本支出 | $-179.5M | — |
| 自由现金流率自由现金流/营收 | -21.8% | — |
| 资本支出强度资本支出/营收 | 11.3% | 4.8% |
| 现金转化率经营现金流/净利润 | — | 1.68× |
| 过去12个月自由现金流最近4个季度 | $-439.9M | — |
8季度趋势，按日历期对齐
经营现金流ACHCWU
| Q1 26 | — | $109.0M | ||
| Q4 25 | $-86.3M | $135.4M | ||
| Q3 25 | $73.2M | $260.4M | ||
| Q2 25 | $133.5M | $-300.0K | ||
| Q1 25 | $11.5M | $148.2M | ||
| Q4 24 | $116.7M | $134.0M | ||
| Q3 24 | $163.1M | $212.1M | ||
| Q2 24 | $171.1M | $-33.8M |
自由现金流ACHCWU
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $115.5M | ||
| Q3 25 | $-63.0M | $252.7M | ||
| Q2 25 | $-34.2M | $-7.8M | ||
| Q1 25 | $-163.2M | $144.8M | ||
| Q4 24 | $-86.8M | $119.7M | ||
| Q3 24 | $-27.1M | $205.1M | ||
| Q2 24 | $16.9M | $-38.9M |
自由现金流率ACHCWU
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | 11.9% | ||
| Q3 25 | -7.4% | 25.6% | ||
| Q2 25 | -3.9% | -0.8% | ||
| Q1 25 | -21.2% | 15.4% | ||
| Q4 24 | -11.2% | 11.8% | ||
| Q3 24 | -3.3% | 20.6% | ||
| Q2 24 | 2.1% | -3.8% |
资本支出强度ACHCWU
| Q1 26 | — | 4.8% | ||
| Q4 25 | 11.3% | 2.0% | ||
| Q3 25 | 16.0% | 0.8% | ||
| Q2 25 | 19.3% | 0.8% | ||
| Q1 25 | 22.7% | 0.4% | ||
| Q4 24 | 26.3% | 1.4% | ||
| Q3 24 | 23.3% | 0.7% | ||
| Q2 24 | 19.4% | 0.5% |
现金转化率ACHCWU
| Q1 26 | — | 1.68× | ||
| Q4 25 | — | 1.18× | ||
| Q3 25 | 2.02× | 1.87× | ||
| Q2 25 | 4.43× | -0.00× | ||
| Q1 25 | 1.37× | 1.20× | ||
| Q4 24 | 3.58× | 0.35× | ||
| Q3 24 | 2.39× | 0.80× | ||
| Q2 24 | 2.18× | -0.24× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACHC
| Acute Inpatient Psychiatric Facilities | $451.2M | 55% |
| Comprehensive Treatment Centers | $144.2M | 18% |
| Medicare | $113.7M | 14% |
| Residential Treatment Centers | $89.7M | 11% |
| Self Payor | $16.1M | 2% |
| Other Payor | $10.7M | 1% |
WU
暂无分部数据
